Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the appointment of Dr. Jeanette Wood as Chief Scientific Officer and Dr. Joseph McCracken to the Board of Directors.
Dr. Wood joins Genkyotex with more than 30 years research experience in the pharmaceutical industry, most recently at AstraZeneca.
Help employers find you! Check out all the jobs and post your resume.
